ES2099048T3 - Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo. - Google Patents

Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo.

Info

Publication number
ES2099048T3
ES2099048T3 ES94919912T ES94919912T ES2099048T3 ES 2099048 T3 ES2099048 T3 ES 2099048T3 ES 94919912 T ES94919912 T ES 94919912T ES 94919912 T ES94919912 T ES 94919912T ES 2099048 T3 ES2099048 T3 ES 2099048T3
Authority
ES
Spain
Prior art keywords
ropivacaine
manufacture
pharmaceutical product
analgesic effect
minimum motor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919912T
Other languages
English (en)
Spanish (es)
Other versions
ES2099048T1 (es
Inventor
Arne Torsten Eek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2099048(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of ES2099048T1 publication Critical patent/ES2099048T1/es
Application granted granted Critical
Publication of ES2099048T3 publication Critical patent/ES2099048T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Medicinal Preparation (AREA)
ES94919912T 1993-06-28 1994-05-26 Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo. Expired - Lifetime ES2099048T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (2)

Publication Number Publication Date
ES2099048T1 ES2099048T1 (es) 1997-05-16
ES2099048T3 true ES2099048T3 (es) 2002-11-16

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919912T Expired - Lifetime ES2099048T3 (es) 1993-06-28 1994-05-26 Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo.

Country Status (32)

Country Link
US (2) US5670524A (cg-RX-API-DMAC7.html)
EP (1) EP0706395B1 (cg-RX-API-DMAC7.html)
JP (1) JP3725541B2 (cg-RX-API-DMAC7.html)
CN (1) CN1074918C (cg-RX-API-DMAC7.html)
AT (1) ATE216237T1 (cg-RX-API-DMAC7.html)
BR (1) BR9406865A (cg-RX-API-DMAC7.html)
CA (1) CA2165446C (cg-RX-API-DMAC7.html)
CZ (1) CZ283300B6 (cg-RX-API-DMAC7.html)
DE (2) DE69430427T2 (cg-RX-API-DMAC7.html)
DK (1) DK0706395T3 (cg-RX-API-DMAC7.html)
EE (1) EE03205B1 (cg-RX-API-DMAC7.html)
ES (1) ES2099048T3 (cg-RX-API-DMAC7.html)
FI (1) FI956269A0 (cg-RX-API-DMAC7.html)
GR (1) GR970300013T1 (cg-RX-API-DMAC7.html)
HU (1) HU218949B (cg-RX-API-DMAC7.html)
IL (1) IL110006A (cg-RX-API-DMAC7.html)
IS (1) IS4174A (cg-RX-API-DMAC7.html)
LT (1) LT3449B (cg-RX-API-DMAC7.html)
LV (1) LV12918B (cg-RX-API-DMAC7.html)
MY (1) MY119360A (cg-RX-API-DMAC7.html)
NO (1) NO955313L (cg-RX-API-DMAC7.html)
NZ (1) NZ268110A (cg-RX-API-DMAC7.html)
PH (1) PH31258A (cg-RX-API-DMAC7.html)
PL (1) PL175518B1 (cg-RX-API-DMAC7.html)
PT (1) PT706395E (cg-RX-API-DMAC7.html)
RU (1) RU2152215C1 (cg-RX-API-DMAC7.html)
SA (1) SA94150010B1 (cg-RX-API-DMAC7.html)
SE (1) SE9302218D0 (cg-RX-API-DMAC7.html)
SG (1) SG49078A1 (cg-RX-API-DMAC7.html)
SK (1) SK280111B6 (cg-RX-API-DMAC7.html)
TW (1) TW285640B (cg-RX-API-DMAC7.html)
WO (1) WO1995000148A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CA2871821C (en) * 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
ES2981043T3 (es) 2013-02-28 2024-10-07 Journey Medical Corp Procedimiento para fabricar tosilato de glicopirrolato treo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
ES2099048T1 (es) 1997-05-16
SK164695A3 (en) 1996-07-03
LV12918B (en) 2003-03-20
US5670524A (en) 1997-09-23
FI956269L (fi) 1995-12-27
SK280111B6 (sk) 1999-08-06
NO955313D0 (no) 1995-12-27
TW285640B (cg-RX-API-DMAC7.html) 1996-09-11
SE9302218D0 (sv) 1993-06-28
WO1995000148A1 (en) 1995-01-05
HK1010344A1 (en) 1999-06-17
DE706395T1 (de) 1997-09-04
GR970300013T1 (en) 1997-05-31
CA2165446A1 (en) 1995-01-05
DE69430427D1 (de) 2002-05-23
HU218949B (hu) 2001-01-29
RU2152215C1 (ru) 2000-07-10
CZ336495A3 (en) 1996-06-12
IL110006A (en) 1999-01-26
EP0706395A1 (en) 1996-04-17
DK0706395T3 (da) 2002-07-22
EE03205B1 (et) 1999-08-16
NO955313L (no) 1995-12-27
PL312198A1 (en) 1996-04-01
JPH09500620A (ja) 1997-01-21
FI956269A7 (fi) 1995-12-27
IL110006A0 (en) 1994-11-11
HUT75115A (en) 1997-04-28
ATE216237T1 (de) 2002-05-15
CN1074918C (zh) 2001-11-21
IS4174A (is) 1994-12-29
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
LT3449B (en) 1995-10-25
AU692161B2 (en) 1998-06-04
JP3725541B2 (ja) 2005-12-14
US5834489A (en) 1998-11-10
DE69430427T2 (de) 2002-11-14
LTIP1958A (en) 1995-01-31
PL175518B1 (pl) 1999-01-29
CN1126435A (zh) 1996-07-10
CA2165446C (en) 2005-07-05
MY119360A (en) 2005-05-31
AU7086694A (en) 1995-01-17
SA94150010B1 (ar) 2006-04-04
FI956269A0 (fi) 1995-12-27
BR9406865A (pt) 1996-03-26
NZ268110A (en) 1999-06-29
PH31258A (en) 1998-06-18
SG49078A1 (en) 1998-05-18
EP0706395B1 (en) 2002-04-17
CZ283300B6 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
ES2191682T3 (es) Nueva formulacion farmaceutica.
AU7327294A (en) Methods and articles for administering drug to the oral cavity
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
CA2264852A1 (en) Use of methylphenidate or a pharmaceutically acceptable salt thereof
ES2128761T3 (es) Formulacion de tirilazad con cosolvente para administracion parenteral.
HU9201577D0 (en) Pharmaceutical preparatives containing biophosphonate squalene synthetase inhibitors and method for producing the active substances
WO1994027589A3 (en) Antidepressant dosage form
SE9503143D0 (sv) New preparation
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
FI954580A7 (fi) HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon
ES2099048T3 (es) Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo.
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
ITRM930286A0 (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
NZ324118A (en) Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
NL300094I1 (nl) Combinatie van budeonide en formoterol, desgewenstin de vorm van een farmaceutisch aanvaardbaar zou t, ester en/of hydraat.
MX9200214A (es) Producto farmaceutico que comprende granisetron y dexametasona.
EP0676206A4 (cg-RX-API-DMAC7.html)
FI950029L (fi) Uusia analgeettisia ja nootrooppisia lääkeaineita
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
ITDP920008A1 (it) Ustion-guariflash/ prodotto terapeutico per ustioni e piaghe infette, abrasioni, irritazioni cutanee, escoriazioni, senza controinicazioni,per uso esterno. farmaco di nuovissima invenzione, inesistente in commercio, tanto in italia che all'estero.
ZA9410116B (en) Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 706395

Country of ref document: ES